The Europe Nucleic Acid Isolation and Purification Market would witness market growth of 8.8% CAGR during the forecast period (2023-2030).
There is an increasing demand for point-of-care testing, driving the development of portable and rapid nucleic acid isolation devices that can be used in decentralized settings such as clinics, remote locations, or even directly at the patient's side. These advancements enable quicker and more immediate diagnostic decisions, particularly in emergency situations or resource-limited environments. Point-of-care nucleic acid extraction devices are instrumental in expediting the diagnostic process and improving patient outcomes.
There is a growing focus on developing specialized extraction kits tailored for specific sample types or applications. These kits are optimized to extract nucleic acids from diverse sources efficiently. Tailored kits enhance the efficiency and accuracy of nucleic acid isolation for specific purposes, whether it's environmental samples, clinical specimens, forensic materials, or agricultural sources. This trend ensures that the extraction process is optimized for varying sample types, leading to higher quality and better outcomes in downstream applications.
Europe is experiencing demographic changes, with a growing proportion of elderly citizens. This demographic shift leads to increased healthcare expenditure due to higher utilization of healthcare services. For example, countries like Germany and Italy have a substantial percentage of their populations aged 65 and older, resulting in higher healthcare costs associated with age-related conditions and long-term care. Therefore, rising investments in healthcare facilities in Europe is expected to drive the growth of the market in the future.
The Germany market dominated the Europe Nucleic Acid Isolation and Purification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $715.9 million by 2030. The UK market is exhibiting a CAGR of 7.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.6% during (2023 - 2030).
Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research, and Personalized Medicine & Others. Based on Product, the market is segmented into Reagents, Kits, and Instruments. Based on Method, the market is segmented into Magnetic Beads, Column Based, Reagent Based, and Others. Based on Type, the market is segmented into Plasmid DNA Isolation & Purification, Total RNA Isolation & Purification, Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, microRNA Isolation & Purification, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Nucleic Acid Isolation and Purification Market will Hit $11.5 Billion by 2030, at a CAGR of 9.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.
By Application
By Product
By Method
By Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 